Metraipolis › archive › dc_2994b83d1998

Teclistamab Dosing Strategies in Relapsed/Refractory Myeloma: A Real-World Comparison of Weekly and Biweekly Versus Fixed Intervals — Europe PMC PMID:41228360

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41228360
DOI
10.3390/cancers17213569
License (as archived)
solo-consultazione
Archived
2026-11-08T18:58:13.301Z
SHA-256 of the archived text
71adf467aaa5f71dcb77a90f1b3a7522cfd9e5405ed42a7c7a16d1a1b47a7e0e
Stable URL of this page
https://metraipolis.com/documento/dc_2994b83d1998

How to cite

Teclistamab Dosing Strategies in Relapsed/Refractory Myeloma: A Real-World Comparison of Weekly and Biweekly Versus Fixed Intervals — Europe PMC PMID:41228360 — Europe PMC (en), https://europepmc.org/article/MED/41228360 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2994b83d1998 (Metraipolis archive dc_2994b83d1998, sha256 71adf467aaa5f71dcb77a90f1b3a7522cfd9e5405ed42a7c7a16d1a1b47a7e0e)
BibTeX
@misc{dc2994b83d1998,
  title = {Teclistamab Dosing Strategies in Relapsed/Refractory Myeloma: A Real-World Comparison of Weekly and Biweekly Versus Fixed Intervals — Europe PMC PMID:41228360},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41228360},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2994b83d1998; sha256 71adf467aaa5f71dcb77a90f1b3a7522cfd9e5405ed42a7c7a16d1a1b47a7e0e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41228360. Agents can read the archived copy with the MCP tool read_document.